| P2093 | author name string | Daniel Wendling | |
| | Evelyne Racadot | |
| | Jean-Pierre Cedoz | |
| P2860 | cites work | The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy | Q34016674 |
| | Pathophysiology of psoriasis: recent advances on IL-23 and Th17 cytokines | Q37051513 |
| | The IL-23/IL-17 axis in inflammation | Q42825302 |
| | The clinical role of IL-23p19 in patients with rheumatoid arthritis. | Q53563550 |
| | Serum matrix metalloproteinase 3 is an independent predictor of structural damage progression in patients with ankylosing spondylitis. | Q54457120 |
| | The IL23R Arg381Gln non-synonymous polymorphism confers susceptibility to ankylosing spondylitis | Q57307105 |
| | Association of interleukin-23 receptor variants with ankylosing spondylitis | Q57674028 |
| | Serum IL-17, BMP-7, and bone turnover markers in patients with ankylosing spondylitis | Q79973633 |
| | Etanercept reduces the serum levels of interleukin-23 and macrophage inflammatory protein-3 alpha in patients with rheumatoid arthritis | Q80588106 |
| | Th1/Th17 cytokine profiles in patients with reactive arthritis/undifferentiated spondyloarthropathy | Q81442977 |
| | Understanding the IL-23-IL-17 immune pathway | Q81485100 |
| P433 | issue | 2 | |
| P304 | page(s) | 187-190 | |
| P577 | publication date | 2008-09-27 | |
| P1433 | published in | Clinical Rheumatology | Q15754927 |
| P1476 | title | Serum and synovial fluid levels of p40 IL12/23 in spondyloarthropathy patients | |
| P478 | volume | 28 | |